New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 23, 2014
07:43 EDTLMNXLuminex upside potential underappreciated, says Leerink
Leerink says its due diligence indicates the upside potential of Luminex shares is being underappreciated at current levels. The firm thinks the company's Technology unit is a growth business and it keeps an Outperform rating on the name with a $23 price target.
News For LMNX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 26, 2015
08:33 EDTLMNXLuminex submits 510(k) application for the NxTAG respiratory pathogen panel
Luminex has submitted a 510(k) application to the FDA for the company's NxTAG Respiratory Pathogen Panel, a respiratory assay that will enable laboratories to simultaneously detect 21 respiratory pathogens in a single closed tube system in a format that scales to changes in throughput requirements and responds to seasonal changes in demand.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use